Co-Diagnostics( CODX 0.99%) reported a steep revenue decline in Q2 2025, driven by the absence of grant income. Management ...

Q3 2025 Outlook -- Net sales are forecasted at $15.9 million for Q3 2025, representing year-over-year growth of approximately ...

Zoetis’ second quarter saw revenue and adjusted earnings surpass Wall Street expectations, but the market responded ...

Integra LifeSciences’ second quarter results reflected steady execution amid ongoing operational transformation efforts.

Q2 2025 Earnings Call Transcript August 13, 2025 BiomX Inc. beats earnings expectations. Reported EPS is $-0.19, expectations ...

Q2 2025 Earnings Call Transcript August 13, 2025 Xos, Inc. beats earnings expectations. Reported EPS is $-0.91, expectations ...

Antofagasta plc ( OTC:ANFGF) Q2 2025 Earnings Conference Call August 14, 2025 9:00 AM ET Ivan Arriagada Herrera - Chief Executive Officer Mauricio Ortiz - Chief Financial Officer Rosario Orchard - ...

Q2 2025 Earnings Conference Call August 14, 2025 6:00 AM ETCompany ParticipantsHangyu Li - Finance DirectorTongbo Liu ...

Total Revenue-- $104,000,000 in total revenue (GAAP) for Q2 2025, reflecting 30.6% year-over-year growth mainly driven by increased revenue from major business operations. Subscription Revenue-- ...

Live Updates Live Coverage Has Ended Guidance is In 5:27 pm Here’s what the company said: “Now turning to guidance for Q3 and ...

Inventory-- Management cited a high level of finished goods from the prior year, with two SKUs being sold at a discount while the rest are performing at regular retail channels. Retail channel growth- ...

Operator: Good morning and welcome to the ARS Pharmaceuticals Conference Call. [Operator Instructions] Please be advised ...